focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGresham Regulatory News (GHT)

Share Price Information for Gresham (GHT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 162.00
Bid: 160.00
Ask: 164.00
Change: 0.00 (0.00%)
Spread: 4.00 (2.50%)
Open: 162.00
High: 162.00
Low: 162.00
Prev. Close: 162.00
GHT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Gresham Technologies PLC

12 Apr 2024 11:05

RNS Number : 4593K
Mission Trail Capital Mgmt LLC
12 April 2024
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Mission Trail Capital Management, LLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Joshua Braden

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Gresham Technologies PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

9 April 2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

5P Ordinary Share

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

0

0

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

0

0

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

5P Ordinary Share

Sale

 

1,870,000

160.3 GBP

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

11 April 2024

Contact name:

Joshua Braden

Telephone number*:

+1 (512) 537-8677

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETSFUSUEELSELL
Date   Source Headline
30th Dec 202012:31 pmRNSResult of General Meeting
23rd Dec 20202:00 pmRNSSignificant Clareti Contract Win with Global Bank
11th Dec 20207:00 amRNSNotice of General Meeting and Circular
3rd Dec 202012:37 pmRNSExercise of Options
23rd Nov 20207:00 amRNSSignificant Clareti Contract with Global Bank
2nd Nov 20202:17 pmRNSHolding(s) in Company
27th Oct 20207:00 amRNSTrading Update
15th Oct 20207:00 amRNSExercise of Options
12th Oct 20207:00 amRNSBoard Changes
5th Oct 20207:00 amRNSExercise of Options
23rd Sep 202012:24 pmRNSExercise of Options
15th Sep 20205:04 pmRNSHolding(s) in Company
30th Jul 202012:28 pmRNSChairman designate dealing
29th Jul 20207:00 amRNSAcquisition of Inforalgo Information Technology
28th Jul 20204:35 pmRNSHolding(s) in Company
28th Jul 20201:34 pmRNSHolding(s) in Company
21st Jul 20207:01 amRNSBoard Changes
21st Jul 20207:00 amRNSHalf-year Report
16th Jul 20207:00 amRNSNotice of Interim Results and Presentations
6th Jul 20201:42 pmRNSHolding(s) in Company
6th Jul 20201:40 pmRNSHolding(s) in Company
6th Jul 20207:00 amRNSTrading Update
11th Jun 20203:21 pmRNSHolding(s) in Company
10th Jun 202012:00 pmRNSSignificant Clareti Contract Win with Global Bank
4th Jun 202010:28 amRNSPDMR Dealing
19th May 20201:03 pmRNSHolding(s) in Company
14th May 202012:23 pmRNSResult of AGM
14th May 20207:00 amRNSAGM Statement
6th May 20207:00 amRNSAGM Change of Location
20th Apr 20207:00 amRNSTrading Update – COVID-19 Impact
2nd Apr 20207:00 amRNSNotice of AGM and Dividend Timetable
31st Mar 20207:00 amRNSDirectors Share Awards
27th Mar 20201:33 pmRNSHolding(s) in Company
10th Mar 20207:00 amRNSFinal Results
6th Mar 20201:58 pmRNSUpdate on Private Investor Presentation
4th Mar 20207:00 amRNSNotice of Results & Analyst Presentation
3rd Feb 20207:00 amRNSElectronic Communications
28th Jan 20203:13 pmRNSHolding(s) in Company
6th Jan 20207:00 amRNSTrading Update
3rd Jan 20201:27 pmRNSHolding(s) in Company
27th Dec 20192:55 pmRNSHolding(s) in Company
23rd Dec 20197:00 amRNSClareti Contract Win and Trading Update
25th Sep 20197:00 amRNSExercise of Options
20th Sep 20197:00 amRNSGresham and ANZ partnership
2nd Sep 201911:11 amRNSHolding(s) in Company
2nd Aug 20195:46 pmRNSHolding(s) in Company
23rd Jul 20197:00 amRNSHalf-year Report
17th Jul 20197:00 amRNSNotice of Results & Analyst Presentation
4th Jul 20197:00 amRNSTrading Update
28th Jun 20197:00 amRNSStrategic fintech partner signs Clareti agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.